Pharmafile.com’s weekly COVID-19 news round-up
June 16, 2021Research and Development
The past week has seen quite a mixed bag when it comes to COVID-19 news, an AstraZeneca antibody has failed …
Ground-breaking COVID antibody treatment proven to save lives
June 16, 2021Research and Development COVID-19, UK, antibodies, trial
Results from Regeneron’s Recovery trial, investigating a potent monoclonal antibody combination treatment in hospitalised patients with severe COVID-19, have shown …
Signite’s sustainable decorating solution to reduce label waste by 50%
June 16, 2021Research and Development
ACTEGA has officially launched Signite, a new decorating solution designed to significantly reduce waste in label production. The hope is …
Avadel’s narcolepsy Phase III trial shows positive results
June 16, 2021Research and Development
Avadel’s Phase III trial for FT218 in patients with narcolepsy has shown positive results. The data from the trial demonstrated …
AstraZeneca antibody fails to prevent COVID in exposed patients
June 15, 2021Manufacturing and Production AstraZeneca, COVID-19, Primary Endpoint, antibody, trial
AstraZeneca has failed to reach the primary endpoint in their Storm Chaser trial, assessing the safety and efficacy of AZD7442, …
Novo Holdings acquires BBI Group in £400 million deal
June 15, 2021Manufacturing and Production acqusition, deal, finance
Novo Holdings, a holding company of the Novo Group, has acquired BBI Group from Exponent for an enterprise value of …
Biogen Phase III choroideremia study did not meet primary endpoint
June 15, 2021Manufacturing and Production Biogen, choroideremia, phase III
Biogen has announced that its investigational gene therapy study for the potential treatment of choroideremia did not meet its primary …
Bone regeneration stem cell “putty” sees positive results in trials
June 15, 2021Manufacturing and Production Cell regeneration, Stem cells, bone, platform, technology
Belgian clinical stage company, Novadip Biosciences, has announced positive results from its Phase I trial of its autologous cell-based osteogenic …
Cognito Therapeutics initiates Down syndrome Alzheimer’s study
June 15, 2021Manufacturing and Production
Cognito Therapeutics are going to run a second digital therapeutic study evaluating individuals who have the genetic rare disease, Down …
Janssen CLL treatment combination sees success in trials
June 14, 2021Sales and Marketing CLL, Janssen
Janssen has announced positive data from its Phase III GLOW study, with the combination of imbruvica (ibrutinib) plus venetoclax (I+V) …
EMA official recommends avoiding AstraZeneca vaccine
June 14, 2021Sales and Marketing
A senior executive at the EMA recommended abandoning the use of the AstraZeneca vaccine in the EU where alternatives are …
NICE recommends treatments for rare form of colorectal cancer
June 14, 2021Sales and Marketing
NICE has recommended BMS’s nivolumab plus ipilimumab (also known as Opdivo and Yervoy) to treat people with a rare form …
Experimental COVID antibody treatment successful in trials
June 14, 2021Sales and Marketing COVID-19, antibody therapy, celltrion, phase III
Celltrion has announced positive top-line data for its experimental antibody COVID-19 treatment, with Phase III trials finding it safe and …
Germany demands that J&J replace contaminated vaccine doses
June 14, 2021Sales and Marketing
Germany’s health ministry has demanded that J&J must deliver 6.5 million COVID-19 vaccine doses to Germany in July to make …
Third FDA panel member quits over controversial Alzheimer’s drug approval
June 11, 2021Medical Communications
The third FDA advisory panel member has quit over the approval of a controversial new Alzheimer’s drug. Biogen’s drug, aducanumab, …
“The future of pain care”: Virtual reality therapy proven to aid chronic pain
June 11, 2021Medical Communications CBT, Virtual reality, chronic pain management, technology
A novel digital therapeutics software, DTxP, has shown statistically significant benefits for patients with chronic low back pain (CLBP) in …
G7: UK to donate 100 million surplus vaccine doses
June 11, 2021Medical Communications Boris Johnson, COVID-19, G7, Joe Biden, UK, US, Vaccine
Boris Johnson has announced at the G7 meeting in Cornwall that the UK will donate over 100 million surplus doses …
Sutimlimab meets primary endpoint in treating cold agglutinin disease
June 11, 2021Medical Communications
A Phase III study evaluating the safety and efficacy of sutimlimab in people with cold agglutinin disease (CAD) met its …
Pharmafile.com’s top 10 news stories of the week
June 11, 2021Medical Communications
Among our ten most-read stories this week: AstraZeneca vs GSK: Cancer drug court battle could cost hundreds of millions; New …
Phase III breast cancer trial meets primary endpoint
June 10, 2021Byondis has revealed positive Phase III results for (ADC) [vic-]trastuzumab duocarmazine (SYD985) in patients with HER2-positive unresectable locally advanced or …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
